Literature DB >> 10362785

Microglia in Alzheimer's disease and transgenic models. How close the fit?

D W Dickson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10362785      PMCID： PMC1866628          DOI： 10.1016/S0002-9440(10)65416-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  57 in total

1.  Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils.

Authors:  J El Khoury; S E Hickman; C A Thomas; L Cao; S C Silverstein; J D Loike
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

Review 2.  Inflammation and Alzheimer's disease pathogenesis.

Authors:  J Rogers; S Webster; L F Lue; L Brachova; W H Civin; M Emmerling; B Shivers; D Walker; P McGeer
Journal:  Neurobiol Aging       Date:  1996 Sep-Oct       Impact factor: 4.673

3.  P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain.

Authors:  L S Higgins; G M Murphy; L S Forno; R Catalano; B Cordell
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

4.  Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor.

Authors:  D M Paresce; R N Ghosh; F R Maxfield
Journal:  Neuron       Date:  1996-09       Impact factor: 17.173

5.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

6.  Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia.

Authors:  D Giulian; L J Haverkamp; J H Yu; W Karshin; D Tom; J Li; J Kirkpatrick; L M Kuo; A E Roher
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

7.  Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease.

Authors:  E Masliah; A Sisk; M Mallory; L Mucke; D Schenk; D Games
Journal:  J Neurosci       Date:  1996-09-15       Impact factor: 6.167

Review 8.  Reactive nitrogen intermediates in human neuropathology: an overview.

Authors:  C F Brosnan; L Battistini; C S Raine; D W Dickson; A Casadevall; S C Lee
Journal:  Dev Neurosci       Date:  1994       Impact factor: 2.984

9.  The impact of microglia-derived cytokines upon gliosis in the CNS.

Authors:  D Giulian; J Li; X Li; J George; P A Rutecki
Journal:  Dev Neurosci       Date:  1994       Impact factor: 2.984

10.  Association of A beta 40-positive senile plaques with microglial cells in the brains of patients with Alzheimer's disease and in non-demented aged individuals.

Authors:  H Fukumoto; A Asami-Odaka; N Suzuki; T Iwatsubo
Journal:  Neurodegeneration       Date:  1996-03
View more
  18 in total

Review 1.  Membrane biophysics and mechanics in Alzheimer's disease.

Authors:  Xiaoguang Yang; Sholpan Askarova; James C-M Lee
Journal:  Mol Neurobiol       Date:  2010-05-01       Impact factor: 5.590

2.  Effects of fatty acid unsaturation numbers on membrane fluidity and α-secretase-dependent amyloid precursor protein processing.

Authors:  Xiaoguang Yang; Wenwen Sheng; Grace Y Sun; James C-M Lee
Journal:  Neurochem Int       Date:  2010-12-22       Impact factor: 3.921

Review 3.  Neuroprotective roles of the P2Y(2) receptor.

Authors:  Gary A Weisman; Deepa Ajit; Richard Garrad; Troy S Peterson; Lucas T Woods; Christina Thebeau; Jean M Camden; Laurie Erb
Journal:  Purinergic Signal       Date:  2012-04-14       Impact factor: 3.765

Review 4.  Macrophages in Alzheimer's disease: the blood-borne identity.

Authors:  David Gate; Kavon Rezai-Zadeh; Dominique Jodry; Altan Rentsendorj; Terrence Town
Journal:  J Neural Transm (Vienna)       Date:  2010-06-02       Impact factor: 3.575

5.  Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice.

Authors:  Suzanne E Hickman; Elizabeth K Allison; Joseph El Khoury
Journal:  J Neurosci       Date:  2008-08-13       Impact factor: 6.167

6.  PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET.

Authors:  Sriram Venneti; Brian J Lopresti; Guoji Wang; Ronald L Hamilton; Chester A Mathis; William E Klunk; Udayan M Apte; Clayton A Wiley
Journal:  Neurobiol Aging       Date:  2008-02-21       Impact factor: 4.673

7.  Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition.

Authors:  Paramita Chakrabarty; Karen Jansen-West; Amanda Beccard; Carolina Ceballos-Diaz; Yona Levites; Christophe Verbeeck; Abba C Zubair; Dennis Dickson; Todd E Golde; Pritam Das
Journal:  FASEB J       Date:  2009-10-13       Impact factor: 5.191

8.  Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease.

Authors:  Shaila P Handattu; David W Garber; Candyce E Monroe; Thomas van Groen; Inga Kadish; Gaurav Nayyar; Dongfeng Cao; Mayakonda N Palgunachari; Ling Li; G M Anantharamaiah
Journal:  Neurobiol Dis       Date:  2009-04-01       Impact factor: 5.996

9.  Secretory phospholipase A2 type III enhances alpha-secretase-dependent amyloid precursor protein processing through alterations in membrane fluidity.

Authors:  Xiaoguang Yang; Wenwen Sheng; Yan He; Jiankun Cui; Mark A Haidekker; Grace Y Sun; James C-M Lee
Journal:  J Lipid Res       Date:  2009-10-05       Impact factor: 5.922

10.  Quantitating the subtleties of microglial morphology with fractal analysis.

Authors:  Audrey Karperien; Helmut Ahammer; Herbert F Jelinek
Journal:  Front Cell Neurosci       Date:  2013-01-30       Impact factor: 5.505
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.